Get started
Author

Tim Atkins

Observed names: Atkins, Tim, T. P. Atkins, T.P. Atkins, Tim P. Atkins
OpenAlex ID: A5083254472
A Live Experimental Vaccine againstBurkholderia pseudomalleiElicits CD4+T Cell–Mediated Immunity, Priming T Cells Specific for 2 Type III Secretion System Proteins
2006 · Ashraful Haque, Karen Chu, et al. · The Journal of Infectious Diseases · 74
Burkholderia pseudomallei: animal models of infection
2008 · Richard W. Titball, Paul Russell, et al. · Transactions of the Royal Society of Tropical Medicine and Hygiene · 70
Flagellar Glycosylation in Burkholderia pseudomallei and Burkholderia thailandensis
2011 · A. E. Scott, S. M. Twine, et al. · Journal of Bacteriology · 52
PDF
Extensive genome analysis of Coxiella burnetii reveals limited evolution within genomic groups
2019 · Claudia M. Hemsley, Paul A. O’Neill, et al. · BMC Genomics · 49
PDF
The global impact and cost-effectiveness of a melioidosis vaccine
2019 · Nantasit Luangasanatip, Stefan Flasche, et al. · BMC Medicine · 19
PDF
Differential cell surface properties of vegetativeBacillus
2009 · J.E. Thwaite, T.R. Laws, et al. · Letters in Applied Microbiology · 15
Assessments of hepatitis B virus-like particles and Crm197 as carrier proteins in melioidosis glycoconjugate vaccines
2020 · Marc Bayliss, Matthew I. Donaldson, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2
PDF
The molecular basis of pathogenicity of Burkholderia pseudomallei.
2003 · Tim Atkins, Petra C. F. Oyston, et al. · 1
Additional file 4: of Extensive genome analysis of Coxiella burnetii reveals limited evolution within genomic groups
2019 · Hemsley, Claudia, O’Neill, Paul, et al. · Figshare
Additional file 2: of The global impact and cost-effectiveness of a melioidosis vaccine
2019 · Nantasit Luangasanatip, Flasche, Stefan, et al. · Figshare
Works count: 25
Citation count: 282
H-index: 6
I10-index: 6
Year
Topic
Type